Found: 105
Select item for more details and to access through your institution.
NAFLD-MASLD-MAFLD continuum: A swinging pendulum?
- Published in:
- Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2024, v. 29, n. 5, p. 2, doi. 10.1016/j.aohep.2024.101526
- By:
- Publication type:
- Article
Viral hepatitis infection and insulin resistance: a review of the pathophysiological mechanisms.
- Published in:
- Salud Pública de México, 2011, v. 53, p. S46
- By:
- Publication type:
- Article
Underlying Mechanisms behind the Brain–Gut–Liver Axis and Metabolic-Associated Fatty Liver Disease (MAFLD): An Update.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 7, p. 3694, doi. 10.3390/ijms25073694
- By:
- Publication type:
- Article
Liver Injury in COVID-19 Patients with Drugs as Causatives: A Systematic Review of 996 DILI Cases Published 2020/2021 Based on RUCAM as Causality Assessment Method.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 9, p. 4828, doi. 10.3390/ijms23094828
- By:
- Publication type:
- Article
Herbal Medicine in Mexico: A Cause of Hepatotoxicity. A Critical Review.
- Published in:
- International Journal of Molecular Sciences, 2016, v. 17, n. 2, p. 235, doi. 10.3390/ijms17020235
- By:
- Publication type:
- Article
MAFLD predicts cardiovascular disease risk better than MASLD.
- Published in:
- Liver International, 2024, v. 44, n. 7, p. 1567, doi. 10.1111/liv.15931
- By:
- Publication type:
- Article
MAFLD: A quick fact check.
- Published in:
- Liver International, 2022, v. 42, n. 12, p. 2903, doi. 10.1111/liv.15422
- By:
- Publication type:
- Article
Hepatic miR-33a/miR-144 and their target gene ABCA1 are associated with steatohepatitis in morbidly obese subjects.
- Published in:
- Liver International, 2016, v. 36, n. 9, p. 1383, doi. 10.1111/liv.13109
- By:
- Publication type:
- Article
Correction to: Superior silybin bioavailability of silybin–phosphatidylcholine complex in oily-medium soft-gel capsules versus conventional silymarin tablets in healthy volunteers.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Molecular Mechanisms Involved in MAFLD in Cholecystectomized Patients: A Cohort Study.
- Published in:
- Genes, 2023, v. 14, n. 10, p. 1935, doi. 10.3390/genes14101935
- By:
- Publication type:
- Article
Recent Updates in the Prevention of Nonalcoholic Fatty Liver Disease.
- Published in:
- Gene Expression (1052-2166), 2023, v. 22, n. 1, p. 19, doi. 10.14218/GE.2022.00005S
- By:
- Publication type:
- Article
Correction to: Association Between Bowel Wall Thickening and Long-Term Outcomes in Decompensated Liver Cirrhosis.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Association Between Bowel Wall Thickening and Long-Term Outcomes in Decompensated Liver Cirrhosis.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 6, p. 2217, doi. 10.1007/s12325-023-02690-z
- By:
- Publication type:
- Article
Artificial Intelligence in Liver Diseases: Recent Advances.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 3, p. 967, doi. 10.1007/s12325-024-02781-5
- By:
- Publication type:
- Article
Why MASLD Lags Behind MAFLD: A Critical Analysis of Diagnostic Criteria Evolution in Metabolic Dysfunction-Associated Liver Diseases.
- Published in:
- Medical Science Monitor, 2024, v. 30, p. 1, doi. 10.12659/MSM.945198
- By:
- Publication type:
- Article
Bilirubin Molecular Species Play an Important Role in the Pathophysiology of Acute-on-Chronic Liver Failure.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 15, p. 8181, doi. 10.3390/ijms25158181
- By:
- Publication type:
- Article
Nutraceuticals and microbiota.
- Published in:
- Minerva Gastroenterology, 2021, v. 67, n. 4, p. 326, doi. 10.23736/S2724-5985.21.02914-4
- By:
- Publication type:
- Article
Obesity and Gallstones.
- Published in:
- Visceral Medicine, 2021, v. 37, n. 5, p. 394, doi. 10.1159/000515545
- By:
- Publication type:
- Article
Impact of anthropometric cut-off values in determining the prevalence of metabolic alterations.
- Published in:
- European Journal of Clinical Investigation, 2016, v. 46, n. 11, p. 940, doi. 10.1111/eci.12672
- By:
- Publication type:
- Article
Severe impairment of patient-reported outcomes in patients with chronic hepatitis C virus infection seen in real-world practices across the world: Data from the global liver registry.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 11, p. 1015, doi. 10.1111/jvh.13741
- By:
- Publication type:
- Article
Review article: thromboelastography in liver diseases.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 4, p. 580, doi. 10.1111/apt.17080
- By:
- Publication type:
- Article
Nuclear Receptors in Nonalcoholic Fatty Liver Disease.
- Published in:
- Journal of Lipids, 2012, p. 1, doi. 10.1155/2012/139875
- By:
- Publication type:
- Article
Response to Letter of Guy D. Eslick.
- Published in:
- 2005
- By:
- Publication type:
- Editorial
Strong Association between Gallstones and Cardiovascular Disease.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2005, v. 100, n. 4, p. 827, doi. 10.1111/j.1572-0241.2005.41214.x
- By:
- Publication type:
- Article
The Amerindian's Genes in the Mexican Population are Associated with Development of Gallstone Disease.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2004, v. 99, n. 11, p. 2166, doi. 10.1111/j.1572-0241.2004.40159.x
- By:
- Publication type:
- Article
Correction to: Superior silybin bioavailability of silybin–phosphatidylcholine complex in oily-medium soft-gel capsules versus conventional silymarin tablets in healthy volunteers*.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Superior silybin bioavailability of silybin–phosphatidylcholine complex in oily-medium soft-gel capsules versus conventional silymarin tablets in healthy volunteers*.
- Published in:
- BMC Pharmacology & Toxicology, 2019, v. 20, n. 1, p. N.PAG, doi. 10.1186/s40360-018-0280-8
- By:
- Publication type:
- Article
Editorial: Treatment with Dual Incretin Receptor Agonists to Maintain Normal Glucose Levels May Also Maintain Normal Weight and Control Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD).
- Published in:
- Medical Science Monitor, 2022, v. 28, p. 1, doi. 10.12659/MSM.938365
- By:
- Publication type:
- Article
Editorial: The Metabolic (Dysfunction) Associated Fatty Liver Disease (MAFLD)-Non- Alcoholic Fatty Liver Disease (NAFLD) Debate: A Forced Consensus and The Risk of a World Divide.
- Published in:
- Medical Science Monitor, 2022, v. 28, p. 1, doi. 10.12659/MSM.938080
- By:
- Publication type:
- Article
Identification of Hepatic Dendritic Cells in Liver Biopsies in Patients with Metabolic DysfunctionAssociated Fatty Liver Diseas (MAFLD) and Obesity.
- Published in:
- Medical Science Monitor, 2022, v. 28, p. e937528-1, doi. 10.12659/MSM.937528
- By:
- Publication type:
- Article
Chronic Hepatitis C Virus Infection, Extrahepatic Disease and the Impact of New Direct-Acting Antivirals.
- Published in:
- Pathogens, 2024, v. 13, n. 4, p. 339, doi. 10.3390/pathogens13040339
- By:
- Publication type:
- Article
Editorial: A year in review: discussions in obesity.
- Published in:
- Frontiers in Endocrinology, 2023, p. 01, doi. 10.3389/fendo.2023.1215596
- By:
- Publication type:
- Article
Current Therapies for Cholestatic Diseases.
- Published in:
- Biomedicines, 2023, v. 11, n. 6, p. 1713, doi. 10.3390/biomedicines11061713
- By:
- Publication type:
- Article
Gastrocolic fistula secondary to adenocarcinoma of the transverse colon: a case report.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Metabolic dysfunction: The silenced connection with fatty liver disease.
- Published in:
- Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2023, v. 28, n. 6, p. 1, doi. 10.1016/j.aohep.2023.101138
- By:
- Publication type:
- Article
Interpretive bias on research evidence: Striving to meet the trustworthiness criteria.
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
Lactate-dehydrogenase associated with mortality in hospitalized patients with COVID-19 in Mexico: a multi-centre retrospective cohort study.
- Published in:
- Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2021, v. 24, p. 1, doi. 10.1016/j.aohep.2021.100338
- By:
- Publication type:
- Article
Reply to: Lactate-dehydrogenase associated with mortality in hospitalized patients with COVID-19 in Mexico.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
NAFLD: Challenges and opportunities to address the public health problem in Latin America.
- Published in:
- Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2021, v. 24, p. 1, doi. 10.1016/j.aohep.2021.100359
- By:
- Publication type:
- Article
Drug-induced liver injury: A management position paper from the Latin American Association for Study of the liver.
- Published in:
- Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2021, v. 24, p. 1, doi. 10.1016/j.aohep.2021.100321
- By:
- Publication type:
- Article
Looking into a new era for the approach of metabolic (dysfunction) associated fatty liver disease.
- Published in:
- Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2020, v. 19, n. 3, p. 227, doi. 10.1016/j.aohep.2020.04.001
- By:
- Publication type:
- Article
Thrombosis of the Portal Venous System in Cirrhotic vs. Non-Cirrhotic Patients.
- Published in:
- Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2018, v. 17, n. 3, p. 476, doi. 10.5604/01.3001.0011.7392
- By:
- Publication type:
- Article
More Evidence for the Genetic Susceptibility of Mexican Population to Nonalcoholic Fatty Liver Disease through PNPLA3.
- Published in:
- Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2018, v. 17, n. 2, p. 250, doi. 10.5604/01.3001.0010.8644
- By:
- Publication type:
- Article
The Changing Face of the Diagnosis of Chronic and Malignant Liver Diseases: Potential New Biomarkers.
- Published in:
- Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2018, v. 17, n. 1, p. 14, doi. 10.5604/01.3001.0010.7531
- By:
- Publication type:
- Article
Bile Acids in Nonalcoholic Fatty Liver Disease: New Concepts and Therapeutic Advances.
- Published in:
- Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2017, v. 16, n. S1, p. s58, doi. 10.5604/01.3001.0010.5498
- By:
- Publication type:
- Article
The Role of the Gut Microbiota in Bile Acid Metabolism.
- Published in:
- Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2017, v. 16, n. S1, p. s21, doi. 10.5604/01.3001.0010.5672
- By:
- Publication type:
- Article
Bile Acids in Health and Disease Foreword.
- Published in:
- Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2017, v. 16, n. S1, p. s3, doi. 10.5604/01.3001.0010.5492
- By:
- Publication type:
- Article
In memoriam. Thomas Starzl, M.D., Ph.D.
- Published in:
- 2017
- By:
- Publication type:
- Obituary
Could TIPS be Applied in All Kinds of Portal Vein Thrombosis: We are not Sure!
- Published in:
- 2017
- By:
- Publication type:
- Letter to the Editor
The Role of TIPS in Patients with Refractory Ascites and Portal Vein Thrombosis.
- Published in:
- Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2017, v. 16, n. 4, p. 619, doi. 10.5604/01.3001.0010.0310
- By:
- Publication type:
- Article